Markets
markets

Nvidia, AMD tumble as Broadcom reportedly secures OpenAI as a major new customer

For the stock market, AI has been the rising tide that lifts any boat that can loosely be seen as flying its colors.

But in the genesis of the AI trade this morning — the powerful chip designers of the picks and shovels for this gold rush — there’s a little bit of a zero-sum element at play:

Broadcom is flying up double digits on the reported addition of OpenAI as the major customer that’s ordered $10 billion in custom chips, significantly improving its 2026 revenue outlook in the process.

Meanwhile, Nvidia is down 3% and No. 3 US chip player Advanced Micro Devices is faring even worse, as this news comes one day after analysts at Seaport cut that stock to neutral, saying that its AI accelerator business hasn’t gained much traction yet. The Street had been very optimistic about the prospects for its new line of chips.

AMD and Nvidia both reported quarterly sales that exceeded expectations, with guidance for revenues in the current quarter that were also ahead of estimates. Nevertheless, both stocks fell after reporting results. To get a positive reaction as a major AI chip designer this earnings season, it seems you need to have done something so good for your company that it actually hurts your competitors’ outlooks.

As we’ve noted, Nvidia’s data center revenues are extremely concentrated, with just three customers (one of which is suspected to be OpenAI) making up over half of direct hardware sales. And despite the chip designer’s protestations to the contrary, the AI boom is more supply-constrained than demand-constrained. So it makes sense that hyperscalers aiming to equip themselves with state-of-the-art technology are looking to do so from a variety of major suppliers.

In its latest conference call, Nvidia CEO Jensen Huang downplayed the threat of custom chips (or ASICs) muscling in on his turf, and highlighted several of the perceived advantages of choosing his company’s products:

“One of the advantages that we have is that NVIDIA is available in every cloud. We're available from every computer company. We're available from the cloud to on-prem to edge to robotics on the same programming model. And so it's sensible that every framework in the world supports NVIDIA. When you're building a new model architecture, releasing it on NVIDIA is most sensible.

And so the diversity of our platform, both in the ability to evolve into any architecture, the fact that we're everywhere, and also we accelerate the entire pipeline. Everything from data processing, to pre-training, to post-training with reinforcement learning, all the way out to inference. And so, when you build a data center with NVIDIA platform in it, the utility of it is best. The lifetime usefulness is much, much longer.”

“Because our performance per dollar is so incredible, you also have extremely great margins. So, the growth opportunity with NVIDIA's architecture and the gross margins opportunity with NVIDIA's architecture is absolutely the best. And so there's a lot of reasons why NVIDIA is chosen by every cloud and every startup and every computer company. We're really a holistic, full-stack solution for AI factories.”

More Markets

See all Markets
markets
Luke Kawa
9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.